WebApr 14, 2024 · Um 09:19 Uhr stieg die CureVac -Aktie. In der Tradegate-Sitzung kletterte das Papier um 0,8 Prozent auf 7,20 EUR. Im Tageshoch stieg die CureVac-Aktie bis auf … WebApr 21, 2024 · CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced preclinical data demonstrating immune responses and protective efficacy of a bivalent second-generation COVID-19 vaccine candidate jointly …
Press releases GSK
WebJan 6, 2024 · The case traces back to a licensing deal Tesaro struck with AstraZeneca back in 2012 — years before it was snapped up by GSK for $5.1 billion — which led to the approval of Zejula in 2024 for ... WebMar 11, 2024 · GSK will also support manufacturing of up to 100m doses of CureVac’s first generation COVID-19 vaccine, if approved. ... Forward-looking statements contained in this press release include, but are not limited to, statements regarding the timing of availability of clinical data, program updates and data disclosures related to VIR-7831, the ... padiglione san luca
GSK announces results evaluating its investigational …
WebFeb 3, 2024 · Development to begin immediately targeting vaccine availability in 2024, subject to regulatory approval. GSK will also support manufacture of up to 100 million doses of CureVac’s first generation COVID-19 vaccine CVnCoV in 2024. GlaxoSmithKline plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq: CVAC) today announced a new €150m … WebApr 11, 2024 · CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic … WebFeb 3, 2024 · CureVac Forward-Looking StatementsThis press release contains statements that constitute "forward looking statements" as that term is defined in the United States Private Securities Litigation ... インスタ 動画 編集 音楽